The NIHR Leeds In Vitro Diagnostics Co-operative launched along with eleven other MICs on 1 January 2018, with an investment of more than £14 million from the National Institute for Health Research (NIHR). This funding was awarded for a 5-year period until 31 December 2022.
We are one of four MICs dedicated to supporting diagnostics developers in the design and validation of new diagnostic tests.
Our remit is to
“To catalyse the generation of evidence on commercially-supplied In Vitro Diagnostics (IVD) required by the NHS and by IVD manufacturers; with a focus on clinical areas or themes to provide evidence of the clinical validity, clinical utility, cost-effectiveness and care pathway benefits of commercially-supplied IVDs with the potential to lead to improvements in healthcare services and the quality of life of NHS patients”
The MICs aim to build expertise and capacity in the NHS to develop and evaluate new medical technologies and in vitro diagnostic tests.
Each MIC has a different focus and is hosted by a different NHS trust. A full list of MICs can be found HERE.